Email Print Friendly Share SOUTH SAN FRANCISCO, Calif., June 15, 2019 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the presentation of results... Read More →

Email Print Friendly Share Final Results Presented in Late-Breaking Sessionat Society for Vascular Surgery 2019 Vascular Annual Meeting NATIONAL HARBOR, Md., June 15, 2019 (GLOBE... Read More →

Email Print Friendly Share [Updated Release to Correct Date of Presentation] BETHLEHEM, Pa., June 14, 2019 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a... Read More →

Email Print Friendly Share Unique patent-pending formulation of lamotrigine addresses significant unmet need in pediatric epilepsy patients NDA was submitted in May 2019; product launch... Read More →

Email Print Friendly Share TORONTO, June 12, 2019 (GLOBE NEWSWIRE) — The Canadian Life and Health Insurance Association is urging the federal government to move... Read More →

Email Print Friendly Share MILFORD, OHIO, June 11, 2019 (GLOBE NEWSWIRE) — The traditional model of hospital accreditation is under scrutiny. Lawmakers, the Centers for... Read More →

Email Print Friendly Share KENNETT SQUARE, Pa., June 10, 2019 (GLOBE NEWSWIRE) — Genesis HealthCare, one of the largest post-acute care providers in the United... Read More →

Email Print Friendly Share SM-88 (racemetyrosine) is an oral, investigational cancer metabolism-based therapy that has demonstrated responses across 15 different cancers New oral approach aimed... Read More →

Email Print Friendly Share BROOKLYN, N.Y., June 07, 2019 (GLOBE NEWSWIRE) — AzurRx BioPharma Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), today announced that both the... Read More →

Email Print Friendly Share PARIS and CAMBRIDGE, Mass., June 07, 2019 (GLOBE NEWSWIRE) — Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused... Read More →